Shanghai's action plan for mergers and acquisitions is still very strong! Three years to cultivate 10 head companies, forming a scale of 300 billion mergers and acquisitions, which clearly accelerate the merger of securities companies and build a first-class investment bank. This is a semiconductor leader, a pharmaceutical leader, a new material leader, a brokerage leader, etc., which directly benefits Shanghai local stocks and pays attention to Shanghai's advantages. This time, the merger with assets exceeding 2 trillion is clearly activated, which shows great determination.However, it is a great pity that the China stock market has never had a history of retail investors and institutions getting rich together. Don't deal with hot money and quantification! Foreign investment in A-shares has also become stale and has become fond of speculation. There are always too many routines to create A shares, which is too tiring to play, and the experience is really bad.Yiming Food issued a suggestive announcement on the risk of stock trading. Since November 26, 2024, the company's stock has been trading daily for 11 consecutive times, with a cumulative turnover rate of 66.9%, which is a risk of a sharp decline in the short term. At the same time, several major shareholders reduced their holdings of shares not exceeding 1% of the total share capital. As of the close of December 10, 2024, the three partnership platforms reduced their holdings by 138,200 shares today.
True Vision: The controlling shareholder and others intend to reduce their holdings by 4% in total;Xinhua News Agency: China's monetary policy has changed from "prudent" to "moderately loose" to send a positive signal.Among them, the biggest benefit is the biomedical industry. It is necessary to set up a M&A fund with a scale of 10 billion, which is specifically aimed at the merger and reorganization of the biomedical industry! The focus is on local enterprises in Shanghai, especially the biomedicine of listed companies in Shanghai.
Xinhua News Agency: China's monetary policy has changed from "prudent" to "moderately loose" to send a positive signal.Many of them announced their reduction in the evening, except for the 11-board Yiming food, others also included.Among them, the biggest benefit is the biomedical industry. It is necessary to set up a M&A fund with a scale of 10 billion, which is specifically aimed at the merger and reorganization of the biomedical industry! The focus is on local enterprises in Shanghai, especially the biomedicine of listed companies in Shanghai.
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14